Search
Moderna Inc
MRNAAdd to Watchlist
54.070USD
-2.950-5.17%
Close 07-24 16:00（ET）Quotes delayed by 15 min
21.30BMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-24The current earnings forecast score of Moderna Inc is 5.92, ranking 137 out of 155 in the Pharmaceuticals industry. The average price target is 28.00, with a high of 135.00 and a low of 17.00.
Analyst Rating
Based on
24
analysts
Hold
Current Rating
53.275
Target Price
-6.57%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
160
Total
6
Median
9
Average
Company name
Ratings
Analysts
Moderna Inc
MRNA
24
Amgen Inc
AMGN
38
Biogen Inc
BIIB
38
AbbVie Inc
ABBV
34
Eli Lilly and Co
LLY
34
Pfizer Inc
PFE
32
1
2
3
...
32
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Moderna Inc's expected revenue for the next quarter?
Moderna Inc's expected revenue is 104.00M.
What is Moderna Inc's price target?
Analysts forecast that Moderna Inc's price target is USD 28.00, with the highest forecast at USD 135.00 and the lowest forecast at USD 17.00.
How have Moderna IncMRNA's recent earnings per share performed?
The market expectation was USD -3.40, while Moderna IncMRNA's earnings per share (EPS) for the previous quarter was USD -2.11. EPS for the next quarter is expected at USD -2.08.
What is the analyst rating for Moderna Inc?
Based on the ratings of Moderna Inc's stock from 24 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.